Those two items you point out are actually separate. The $5 copayment is revenue generated to the federal government. That's what we subtract at the end there, I believe, to get down to $20 billion in our presentation. The generic substitution we speak of is the cost of moving from a higher-priced brand to a lower-priced generic.
On October 17th, 2017. See this statement in context.